Mepivacaine Hydrochloride 3% Injection

Hazard statements (CLP)

H336

Code

Statements

H336

May cause drowsiness or dizziness

SECTION 2: Hazards identification

Classification This product is exempt from WHMIS 2015 as a drug product Information provided is for worker education and training purposes Equivalent Class: Specific Target Organ Toxicity – Single Exposure Narcotic effects, Category 3 Equivalent GHS Label Symbol Hazard Statements Warning H336 - May cause drowsiness or dizziness May cause skin and/or eye irritation Causes central nervous system effects such as drowsiness, confusion, excitability and nervousness. Acts as a depressant on the cardiovascular system Avoid use in individuals with hypersensitivities to amide-type anesthetics. Use with caution in individuals with diabetes and/or severe hypertension CONSULT PRODUCT INSERT FOR CLINICAL AND PHARMACOPIAL INFORMATION Signs and Symptoms of Overexposure: Drowsiness, confusion, excitability, nervousness, drop in blood pressure, fatigue, bluish discoloration of fingernails, lips, or skin, difficulties in breathing DOES NOT CONTAIN SODIUM BISULFITE

Prevention

P261 – Do not breathe mist/vapours/spray P271 – Use in a well-ventilated area

Response

P304+P430 – If inhaled – remove victim to fresh air and keep at rest in a position comfortable for breathing P312 – Call a POISON CENTER or doctor/physician if you feel unwell

Storage

P405 – Store locked up

Disposal

P501 – Dispose of contents/container in accordance with local/provincial/federal regulations

2.1 Classification of the substance or mixture

This product is exempt from WHMIS 2015 as a drug product. Information provided is for worker education and training purposes. Equivalent Class: Specific Target Organ Toxicity – Single Exposure: Narcotic effects, Category 3 Equivalent GHS Label Symbol: Hazard Statements: Warning H336 - May cause drowsiness or dizziness May cause skin and/or eye irritation Causes central nervous system effects such as drowsiness, confusion, excitability and nervousness. Acts as a depressant on the cardiovascular system. Avoid use in individuals with hypersensitivities to amide-type anesthetics. Use with caution in individuals with diabetes and/or severe hypertension. CONSULT PRODUCT INSERT FOR CLINICAL AND PHARMACOPIAL INFORMATION Signs and Symptoms of Overexposure: Drowsiness, confusion, excitability, nervousness, drop in blood pressure, fatigue, bluish discoloration of fingernails, lips, or skin, difficulties in breathing. DOES NOT CONTAIN SODIUM BISULFITE